The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 55-60

  Trott, Jana ^a   Gerber, Wolfgang ^a   Hammes, Stefan ^b   Ockenfels, Hans Michael ^a  

^a Klinikum Hanau   (Germany)

^b LASERKLINIK KARLSRUHE   (Germany)

Author keywords

Laser; Psoriasis; PUVA treatment

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; EXCIMER LASER; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PSORIASIS; PUVA; STATISTICAL ANALYSIS; TREATMENT DURATION;

COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, EXCIMER; MALE; MIDDLE AGED; PSORIASIS; PUVA THERAPY; ULTRAVIOLET THERAPY;

EID: 38549181656     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0311     Document Type: Article

References (44)

1. Karrer S, Eholzer C, Ackermann G, Landthaler M, Szeimies RM. Phototherapy of psoriasis: Comparative experience of different phototherapeutic approaches. Dermatology 2001; 202: 108-15.
2. Hönigsmann H, Szelmis RM, Knobler R, Fitzpatrick TB, Pathak MA, Wolff K. Photochemotherapy and photodynamic therapy. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill, 1999: 2880-900.
3. Henseler T, Wolff K, Hönigsmann H, Christophers E. Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres. Lancet 1981; 8225: 853-7.
4. Gasparro FP. The role of PUVA in the treatment of psoriasis. Am J Clin Dermatol 2000; 1(6): 337-48.
5. Spuls PI, Witkamp L, Bossuyt PMM, Bos JD. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 1997; 137: 943-9.
6. Cooper EJ, Herd RM, Priestley GC, Hunter JAA. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol 2000; 25: 111-4.
7. Lüftl M, Degitz K, Plewig G, Röcken M. Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 1997; 133: 1597-603.
8. Coven TR, Walters IB, Cardinale I, Krueger JG. PUVA-induced lymphocyte apoptosis: Mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed 1999; 15: 22-7.
9. Gordon PM, Diffey BL, Matthews JNS, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41(5): 728-32.
10. Van Weelden H, Baartde la Faille H, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990; 70: 212-5.
11. Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, Ferguson J. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003; 148(6): 1194-204.
12. Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in the treatment of psoriasis vulgaris. J Am Acad Dermatol 1999; 40(6): 893-900.
13. Wainwright NJ, Dawe RS, Ferguson J. Narrow-band ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 1998; 139: 410-4.
14. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA follow-up study. N Engl J Med 1997; 336: 1041-5.
15. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a meta-analysis. Arch Dermatol 1998; 134: 1582-5.
16. Krutmann J. Photocarcinogenesis. Schweiz Rundsch Med Prax 2001; 90(8): 297-9.
17. Asawanonda P, Anderson RR, Chang Y, Taylor CY. 308-nm excimer laser for the treatment of psoriasis: a dose response study. Arch Dermatol 2000; 136: 619-24.
18. Gerber W, Arheilger B, Ha TA, Hermann J, Ockenfels HM. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach. Br J Dermatol 2003; 149: 1250-8.
19. Pahlajani N, Katz BJ, Lozano AM, Murphy F, Gottlieb A. Comparison of the efficacy and safety of the 308-nm excimer laser for the treatment of localized psoriasis in adults and in children: a pilot study. Pediatr Dermatol 2005; 22(2): 161-5.
20. Taneja A, Trehan M, Taylor CR. 308-nm excimer laser for the treatment of psoriasis. Arch Dermatol 2003; 139: 759-64.
21. Salam Housman T, Pearce DJ, Feldman SR. A maintenance protocol for psoriasis plaques cleared by the 308-nm excimer laser. J Dermatol Treatment 2004; 15: 94-7.
22. Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002; 47(5): 701-8.
23. Aubin F, Vigan M, Puzenat E, Blanc D, Drobacheff P, Deprez P, Humbert P, Laurent R. Evaluation of novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol 2005; 152: 99-103.
24. Passeron T, Zakaria W, Ostovari N, Perrin C, Larrouy JC, Lacour JP, Ortonne JP. Efficacy of the 308-nm excimer laser in the treatment of mycosis fungoides. Arch Dermatol 2004; 140: 1291-3.
25. Novak Z, Bonis B, Baltas E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Pnotobiol 2002; 67: 32-8.
26. Raulin C, Grema H. Psoriasis vulgaris. Indikation für den Laser? Hautarzt 2003; 54: 242-7.
27. Tzaneva S, Seeber A, Hönigsmann H, Tanew A. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Br J Dermatol 2002; 147: 748-53.
28. Pasker-de Jong CM, Wielink G, van der Valk GM, van der Wilt GJ. Treatment with UV-B for psoriasis and nonmelanoma skin cancer. Arch Dermatol 1999; 135: 834-40.
29. Grundmann-Kollmann M, Tegeder I, Ochsendorf FR, Zollner TM, Ludwig R, Kaufmann R, et al. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations. Br J Dermatol 2001; 144: 991-5.
30. Collins P, Wainwright NJ, Amorim I, Lakshmipathi T, Ferguson J. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach. Br J Dermatol 1996; 135: 248-54.
31. Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesen A, Berne B, et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999; 141: 108-12.
32. Hannuksela A, Pukkala E, Hannuksela M, Karvonen J. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 1996; 35: 685-9.
33. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc 1999; 4(1): 70-2.
34. Stern RS, Laird N. The carcinogenic risk of treatment for severe psoriasis. Cancer 1994; 73: 2759-64.
35. el-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: A review. J Photochem Photobiol 1997; 38(2,3): 99-106.
36. Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrow-band UV-B produces superior clinical and histopathological resolution of moderate-to severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133: 1514-22.
37. Tajbjee SM, Cheung ST, Laube S, Lanigan SW. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis. Br J Dermatol 2005; 153: 960-6.
38. Ortel B, Perl S, Kinaciyan T, et al. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-MOP in the treatment of psoriasis. J Am Acad Dermatol 1993; 29: 736-40.
39. Arnold WP, van Andel P, de Hoop D, de Jong-Tieben L, Visservan Andel M. A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. Br J Dermatol 2001; 145: 352-542.
40. Alexiades-Armenakas MR, Bernstein U, Friedman PM, Geronemus RG. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol 2004; 140: 955-60.
41. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 2005; 152: 981-5.
42. Gupta SN, Taylor CR. 308-nm excimer laser for the treatment of scalp psoriasis. Arch Dermatol 2004; 140: 518-20.
43. Bianchi B, Campolmi P, Mavilia L, Danesi A, Rossi R, Cappugi P. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells apoptosis-related molecules in psoriasis. J Eur Acad Dermatol Venereol 2003; 17: 408-13.
44. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Austin LM, Coven TR, Burack LH, Krueger JG. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. Lab Invest Dermatol 1999; 189: 711-8.